v3.26.1
Stockholders’ Equity (Details) - USD ($)
3 Months Ended 12 Months Ended
Nov. 21, 2025
Feb. 08, 2024
Feb. 07, 2024
Feb. 06, 2024
Mar. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
Sales Agreement [Member]              
Stockholders’ Equity [Line Items]              
Aggregate gross sales price (in Dollars) $ 4,095,176            
Sales Agreement [Member] | Common Stock [Member]              
Stockholders’ Equity [Line Items]              
Aggregate gross sales price (in Dollars) $ 3,150,000            
Net proceeds (in Dollars)         $ 2,303,484   $ 336,000
February 2024 Public Offering [Member]              
Stockholders’ Equity [Line Items]              
Issuance of common stock     82,500        
Proceeds from warrants (in Dollars)         $ 3,400,000    
Percentage of gross proceeds   9.00%          
February 2024 Public Offering [Member] | Pre-funded Warrants [Member]              
Stockholders’ Equity [Line Items]              
Warrants to purchase       1,424,760      
Warrants exercise price (in Dollars per share)         $ 0.001    
Warrants purchase for common stock             1,424,760
February 2024 Public Offering [Member] | Series A Warrants [Member]              
Stockholders’ Equity [Line Items]              
Warrants to purchase     165,000 571,428      
Warrants exercise price (in Dollars per share)         $ 2.25    
Expiration date         Feb. 08, 2029    
February 2024 Public Offering [Member] | Series B Warrants [Member]              
Stockholders’ Equity [Line Items]              
Warrants to purchase     165,000 571,428      
Warrants exercise price (in Dollars per share)         $ 2.25    
Expiration date         Nov. 08, 2024    
February 2024 Public Offering [Member] | Series A warrants and Series B warrants [Member]              
Stockholders’ Equity [Line Items]              
Warrants exercise price (in Dollars per share)     $ 2.099        
February 2024 Public Offering [Member] | Common Stock [Member]              
Stockholders’ Equity [Line Items]              
Warrants exercise price (in Dollars per share)   $ 2.625          
Warrants purchase for common stock   139,108          
February 2024 Public Offering [Member] | Common Stock [Member] | Series A Warrants [Member]              
Stockholders’ Equity [Line Items]              
Warrants to purchase       3,809,520      
Additional shares of common stock       285,714      
February 2024 Public Offering [Member] | Common Stock [Member] | Series A warrants and Series B warrants [Member]              
Stockholders’ Equity [Line Items]              
Warrants exercise price (in Dollars per share)     $ 2.1        
February 2024 Public Offering [Member] | Underwriting Agreement [Member] | Common Stock [Member]              
Stockholders’ Equity [Line Items]              
Issuance of common stock       480,000      
February 2024 Public Offering [Member] | Minimum [Member]              
Stockholders’ Equity [Line Items]              
Percentage of beneficially owned outstanding common stock         9.99%    
February 2024 Public Offering [Member] | Maximum [Member]              
Stockholders’ Equity [Line Items]              
Percentage of beneficially owned outstanding common stock         4.99%    
ATM Offering [Member]              
Stockholders’ Equity [Line Items]              
Percentage of gross proceeds         3.00%    
ATM Offering [Member] | Sales Agreement [Member]              
Stockholders’ Equity [Line Items]              
Net proceeds (in Dollars)           $ 4,351,100  
At-The-Market Offering [Member]              
Stockholders’ Equity [Line Items]              
Sale of stock         2,371,943   251,621
At-The-Market Offering [Member] | Common Stock [Member]              
Stockholders’ Equity [Line Items]              
Sale of stock           3,713,939  
Series B Common Stock [Member] | February 2024 Public Offering [Member]              
Stockholders’ Equity [Line Items]              
Warrants to purchase       3,809,520